Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2006-04-01 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: RIVIERE SALEE (97215), Martinique
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE CORINNE ROSE : revenue, balance sheet and financial ratios
PHARMACIE CORINNE ROSE is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in RIVIERE SALEE (97215),
this company of category PME
shows in 2024 a net income positive of 100 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CORINNE ROSE (SIREN 489210674)
Indicator
2024
2023
Revenue
N/C
N/C
Net income
100 157 €
77 410 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE CORINNE ROSE generates positive net income of 100 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2023-2024: 77 k€ -> 100 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
100 157 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 76%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 40%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
75.7%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
40.441%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE CORINNE ROSE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2023
2024
Debt ratio
115.45
75.7
Financial autonomy
31.82
40.441
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
75.72024
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average-7 pts over 2 years
In 2024, the debt ratio of PHARMACIE CORINNE ROSE (75.70) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
40.44%2024
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+10 pts over 2 years
In 2024, the financial autonomy of PHARMACIE CORINNE ROSE (40.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 55.81. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
55.815
Liquidity indicators evolution PHARMACIE CORINNE ROSE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2023
2024
Liquidity ratio
53.667
55.815
Interest coverage
None
None
Sector positioning
Liquidity ratio
55.812024
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Watch
In 2024, the liquidity ratio of PHARMACIE CORINNE ROSE (55.81) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE CORINNE ROSE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE CORINNE ROSE is estimated at
1 398 265 €
(range 973 730€ - 2 091 885€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
973k€1398k€2091k€
1 398 265 €Range: 973 730€ - 2 091 885€
NAF 5 année 2024
Valuation method used
Net Income Multiple
100 157 €
×
14.0x
=1 398 266 €
Range: 973 730€ - 2 091 886€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CORINNE ROSE with other companies in the same sector:
Frequently asked questions about PHARMACIE CORINNE ROSE
What is the revenue of PHARMACIE CORINNE ROSE ?
The revenue of PHARMACIE CORINNE ROSE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE CORINNE ROSE profitable?
Yes, PHARMACIE CORINNE ROSE generated a net profit of 100 k€ in 2024.
Where is the headquarters of PHARMACIE CORINNE ROSE ?
The headquarters of PHARMACIE CORINNE ROSE is located in RIVIERE SALEE (97215), in the department Martinique.
Where to find the tax return of PHARMACIE CORINNE ROSE ?
The tax return of PHARMACIE CORINNE ROSE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CORINNE ROSE operate?
PHARMACIE CORINNE ROSE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart